Cigna Corporation (CGN.DE) Stock Analysis & Winston Score
Cigna is a large American health insurance and benefits company. It sells medical, dental, vision, and behavioral health insurance plans to employers, governments, and individuals. Cigna also owns Express Scripts, one of the largest pharmacy benefit managers in the United States, which processes prescription drug claims for millions of people. Cigna makes most of its money by collecting premiums from customers and then paying out medical claims, keeping the difference. It also earns fees for managing pharmacy benefits through Express Scripts. The company operates mainly in the United States but has some international health and life insurance businesses. Its pharmacy benefit management arm gives it scale advantages in negotiating drug prices, which acts as a competitive moat. The main risk Cigna faces is rising medical costs — if healthcare utilization increases faster than premiums, profit margins can shrink quickly, as the industry broadly experienced in 2024.
Winston Score: 50/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Good (15/30)
- Growth: Good (10/20)
- Cash Flow: Strong (7/10)
- Stability: Good (6/10)
- Valuation: Strong (8/10)
- Ownership: Weak (2/15)
Key Facts
Price: €237.10
Market Cap: €62.7B
Sector: Healthcare
Industry: Medical - Healthcare Plans
Exchange: Frankfurt Stock Exchange

